- Telehealth Visits
- Insurance plan information
Kerstin Morehead, MD
Rheumatology- Telehealth Visits
- Insurance plan information
Kerstin Morehead, MD
Rheumatology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Rheumatology, American Board of Internal Medicine/Rheumatology
Fellowship
- Rheumatology, UCSF Medical Center - OMAG
Residency
- Internal Medicine, UCSF Medical Center - OMAG
Internship
- Internal Medicine, UCSF Medical Center - OMAG
Degree
- MD, University of Chicago Pritzker School of Medicine
My expertise
Specialties
Conditions
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%22681%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22681%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 67 reviews
- January 23, 20265 out of 5 Stars
My care provider is excellent and always provides alternatives for my care.
- January 19, 20265 out of 5 Stars
Dr. Morehead has been wonderful. It has not been an easy fix for me. But she has always been informative, optimistic, and has listened to my concerns. We have worked together to find the right solution for my issues. I appreciate her very much.
- January 6, 20265 out of 5 Stars
Very pleased with the Doctor she was friendly & put me at ease during exam and questions.
- December 19, 20255 out of 5 Stars
Dr. Morehead is an excellent physician. She took the time to see me at the very last minute. She shows empathy and truly cares.
- December 16, 20255 out of 5 Stars
Dr. Morehead is great.
- December 15, 20255 out of 5 Stars
Most complete exam I've ever had in 70 years. Ordered labs and X-rays stat.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.